Neutrophil-lymphocyte ratio in patients with familial Mediterranean fever

Mehmet Celikbilek1, Serkan Dogan, Lutfi Akyol

  • 1Department of Gastroenterology, Bozok University Medical School, Yozgat, Turkey.

Abstract

Insights

The neutrophil-to-lymphocyte (N/L) ratio is elevated in active familial Mediterranean fever (FMF) patients compared to those in remission and healthy controls. A ratio of 2.63 can help identify active FMF cases.

Area of Science:

  • Immunology
  • Rheumatology
  • Hematology

Background:

  • The neutrophil-to-lymphocyte (N/L) ratio serves as a marker for systemic inflammation.
  • Elevated N/L ratios have been observed in various inflammatory conditions, including familial Mediterranean fever (FMF).

Purpose of the Study:

  • To investigate the relationship between the N/L ratio and the inflammatory status in patients with FMF.
  • To determine if the N/L ratio can differentiate between active FMF, FMF in remission, and healthy controls.

Main Methods:

  • A study involving 115 participants, including FMF patients (active and attack-free periods) and healthy controls.
  • Neutrophil and lymphocyte counts were measured to calculate the N/L ratio.
  • Diagnosis of FMF was confirmed using Tel Hashomer criteria.

Main Results:

  • The N/L ratio was significantly higher in FMF patients experiencing an attack compared to attack-free FMF patients and controls (P < 0.001).
  • An N/L ratio cut-off of 2.63 demonstrated 62% sensitivity and 85% specificity for identifying active FMF.
  • The overall accuracy of the N/L ratio in detecting active FMF was 71%.

Conclusions:

  • The N/L ratio is a valuable indicator of active inflammation in FMF.
  • A threshold N/L ratio of 2.63 can aid in the identification of FMF patients during an active disease flare.

Related Concept Videos